YD Bio launches telehealth platform for cancer detection services Mar 31, 2026 08:05AM
YD Bio outlines integrated oncology platform strategy Mar 17, 2026 08:01AM
YD Bio signs merger MOU with EG BioMed for cancer diagnostics platform Jan 6, 2026 09:04AM
YD Bio outlines 2026 clinical roadmap for eye treatments Jan 5, 2026 09:02AM
YD Bio plans California operations center for U.S. expansion Dec 16, 2025 09:03AM


Dec 2, 2025 09:00AM YD Bio expands blood cancer testing to 44 US states
Nov 24, 2025 09:00AM YD Bio enters U.S. eye care market with FDA-cleared contact lenses
Aug 29, 2025 07:30AM YD Bio completes merger with SPAC, begins trading on NASDAQ